Accès ouvert
2026
article
OpenAlex
X Xu, Yuan Lin, Huangyang Meng, L Zhang et autres
BACKGROUND: Folate receptor alpha (FRα) is overexpressed in various epithelial ovarian carcinomas and has emerged as a potential therapeutic target. However, its expression pattern and clinical significance in borderline ovarian tumors (BOTs) and related low-grade serous tumors remain unclear. This study aimed …
cn
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Yadan Zou, Ruohan Yu, Kun Yang, L Zhang et autres
Background Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease in which treat-to-target management increasingly emphasizes attainment of Lupus Low Disease Activity State (LLDAS). Complete blood count (CBC)-derived inflammatory indices are inexpensive and readily available markers, but their value for predicting subsequent …
cn
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Jiaxi Liu, Wenhui Xie, Y J Cao, L Zhang et autres
BACKGROUND: Rheumatoid arthritis fibroblast‑like synoviocytes (RA‑FLS) exhibit chronic endoplasmic reticulum stress with activation of the IRE1/phospho‑JNK arm of the unfolded protein response; yet, they remain resistant to apoptosis. Although ferroptosis has been implicated in the pathogenesis of rheumatoid arthritis, the mechanisms underlying …
cn
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Yuan Xue, L Zhang, Xianglong Chen, 易湛苗 et autres
BACKGROUND: Platinum resistance is a major determinant of poor prognosis in epithelial ovarian cancer (EOC); however, no reliable pretreatment biomarkers are currently available to guide first-line therapy. This study aimed to develop a plasma cell-free DNA (cfDNA) 5-hydroxymethylcytosine (5hmC) signature for predicting …
cn
(code pays fourni par la source)
2016
article
OpenAlex
Li Xs, Zhang Cj, Yang Kw, Qing‐Nan Tang et autres
OBJECTIVE: To evaluate the impacts of clinical, pathological, and laboratory factors on oncological outcomes of patients with T3N0M0 renal cell carcinoma. METHODS: The clinical data, laboratory exam results, and follow-up outcomes of 182 patients with T3N0M0 renal cell carcinoma who underwent nephrectomy …
cn
(code pays fourni par la source)